DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression-a randomised clinical trial

Jesper Krogh, Poul Videbech, Carsten Thomsen, Christian Gluud, Merete Nordentoft, Jesper Krogh, Poul Videbech, Carsten Thomsen, Christian Gluud, Merete Nordentoft

Abstract

Background: The effect of referring patients from a clinical setting to a pragmatic exercise intervention for depressive symptoms, cognitive function, and metabolic variables has yet to be determined.

Methods: Outpatients with major depression (DSM-IV) were allocated to supervised aerobic or stretching exercise groups during a three months period. The primary outcome was the Hamilton depression score (HAM-D(17)). Secondary outcomes were cognitive function, cardiovascular risk markers, and employment related outcomes.

Results: 56 participants were allocated to the aerobic exercise intervention versus 59 participants to the stretching exercise group. Post intervention the mean difference between groups was -0.78 points on the HAM-D(17) (95% CI -3.2 to 1.6; P = .52). At follow-up, the participants in the aerobic exercise group had higher maximal oxygen uptake (mean difference 4.4 l/kg/min; 95% CI 1.7 to 7.0; P = .001) and visuospatial memory on Rey's Complex Figure Test (mean difference 3.2 points; 95% CI 0.9 to 5.5; P = .007) and lower blood glucose levels (mean difference 0.2 mmol/l; 95% CI 0.0 to 0.5; P = .04) and waist circumference (mean difference 2.2 cm; 95% CI 0.3 to 4.1; P = .02) compared with the stretching exercise group.

Conclusions: The results of this trial does not support any antidepressant effect of referring patients with major depression to a three months aerobic exercise program. Due to lower recruitment than anticipated, the trial was terminated prior to reaching the pre-defined sample size of 212 participants; therefore the results should be interpreted in that context. However, the DEMO-II trial does suggest that an exercise program for patients with depression offer positive short-term effects on maximal oxygen uptake, visuospatial memory, fasting glucose levels, and waist circumference.

Trial registration: ClinicalTrials.gov NCT00695552.

Conflict of interest statement

Competing Interests: Two of the funders (Trygfonden and Nordea-Danmark fonden) are commercial funders. However, none of the authors have any declarations relating to employment, consultancy, patents, products in development or marketed products relating to the commercial funders. Co-author CG is an editor at PLOS ONE. None of the above alters the authors’ adherance to all the PLOS ONE policies on sharing data and materials. Otherwise, the authors have declared that no competing interests exist.

Figures

Figure 1. Flow diagram for the DEMO-II…
Figure 1. Flow diagram for the DEMO-II trial.

References

    1. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. Plos Med 3(11): 2011–2030.
    1. Hammar Å, Årdal G (2009) Cognitive function in major depression - a summary. Front Hum Neurosci 3.
    1. Laursen T, Munk-Olsen T, Nordentoft M, Mortensen P (2007) Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 68(6): 899–907.
    1. Davidson JR (2010) Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 71: Suppl E1.
    1. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, et al. (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22(4): 343–396.
    1. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, et al. (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373 (9665): 746–758.
    1. Kirsch I, Deacon B, Huedo-Medina T, Scoboria A, Moore T, et al. (2008) Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5(2): e45.
    1. Krogh J, Nordentoft M, Sterne J, Lawlor D (2010) The effect of exercise in clinically depressed adults: Systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 72(4): 529–538.
    1. Angevaren M, Aufdemkampe G, Verhaar H, Aleman A,Vanhees L (2008) Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev (3): No.: CD005381.
    1. Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, et al. (2011) Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev (7): CD001800.
    1. Yau SY, Lau BW, Tong JB, Wong R, Ching YP, et al. (2011) Hippocampal neurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed rats. PLoS One 6 (9): e24263.
    1. Gomez-Merino D, Bequet F, Berthelot M, Chennaoui M, Guezennec CY (2001) Site-dependent effects of an acute intensive exercise on extracellular 5-HT and 5-HIAA levels in rat brain. Neurosci Lett 301: 143–146.
    1. Krogh J, Saltin B, Gluud C, Nordentroft M (2009) The DEMO trial: A randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression. J Clin Psychiatry 70(6): 790–800.
    1. Khatri P, Blumenthal J, Babyak M, Craighead E, Herman S, et al. (2001) Effects of exercise training on cognitive functioning among depressed older men and women. J Aging Phys Act 9(1): 43–57.
    1. Bech P, Bech-Andersen G, Schütze T (1999) Mini Internationalt Neuropsykiatrisk Interview. Dansk version 5.0.0. Available: www ccmh dk.
    1. Endicott J, Cohen J, Nee J, Fleiss J, Sarantakos S (1981) Hamilton Depression Rating Scale. Extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 38(1): 98–103.
    1. Bagby RM, Ryder AG, Schuller DR, Marshall MB (2004) The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight? Am J Psychiatry 161(12): 2163–2177.
    1. Bech P (2009) Applied psychometics in clinical psychiatry: The pharmacopsychometric triangle. Acta Pscyhiatr Scand 120 (5): 400–409.
    1. Beck AT, Steer RA, Brown GK (1996) BDI-II manual. 2 ed. New York: Psychological Corporation.
    1. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 3250–3255.
    1. Wechsler D (1955) WAIS manual. The Wechsler Adult Intelligence Scale. New York: Psychological Corporation.
    1. Nelson HE, O’Connell A (1978) Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14(2): 234–244.
    1. Buschke H, Fuld PA (1974) Evaluating storage, retension and retrievel in disordered memory and learning. Neurology 24: 1019–1025.
    1. Meyers J, Meyers K (1995) Rey Complex Figure and Recognition Trial: Professional Manual. Psychological Asessment Resources: Florida.
    1. Wechscler D (1981) The Wechsler Adult Intelligence Scale-Revised. San Antonio, Texas: The Psychological Corporation.
    1. Smith A (1967) The serial sevens substraction test. Arch Neurol 17: 78–80.
    1. Stroop J (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18: 643–662.
    1. Reitan RM (1955) The relation of the Trail Making Test to organic brain damage. J Consult Psychol 193: 393–394.
    1. Borkowski JG, Benton AL, Spreen O (1967) Word Fluency and brain damage. Neuropsychologia 5: 135–140.
    1. Andersen LB (1995) A maximal cycle exercise protocol to predict maximal oxygen uptake. Scand J Med Sci Sports 5: 143–146.
    1. Hollis S, Campbell F (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319: 670–674.
    1. Mallinckrodt C, Clark S, David S (2001) Accounting for dropout bias using mixed-effects models. J Biopharm Stat 11(1& 2): 9–21.
    1. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, et al. (2010) Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects. JAMA 303(12): 1180–1187.
    1. Krogsbøll L, Hróbjartsson A, Gøtzsche P (2009) Spontaneous improvement in randomised clinical trails: meta-analysis of three-armed trials comparing no treatment, placebo and active treatment. BMC Med Res Methodol 9(1): 1–10.
    1. Blumenthal J, Babyak M, Doraiswamy P, Watkins L, Hoffman B, et al. (2007) Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 69(7): 587–596.
    1. Mather AS, Rodriguez C, Guthrie M, McHarg A, Reid I, et al. (2002) Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder: a randomised controlled trial. Brit J Psychiatry 180: 411–415.
    1. Trivedi MH, Greer T, Church T, Carmody T, Grannemann B, et al. (2011) Exercise as an augmentation treatment for nonremitted major depressive disorder: A randomized, parallel dose comparison. J Clin Psychiatry 72(5): 677–684.
    1. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, et al... (2008) Exercise for depression. Cochrane Database Syst Rev(4): No.: CD004366.
    1. Dunn AL, Trivedi MH, Kaplan K, Clark C, Chambliss H (2005) Exercise treatment for depression. Efficacy and dose response. Am J Prev Med 281–8.
    1. Crone D, Johnston L, Gidlow C, Henley C, James D (2008) Uptake and participation in physical activity referral schemes in the UK: An investigation of patients referred with mental health problems. Issues Ment Health Nurs 29(10): 1088–1097.
    1. The LIFE Group (2011) Supporting community-based exercise in long-term neurological conditions: experience from the Long-term Individual Fitness Enablement (LIFE) project. Clin Rehabil 25(7): 579–587.
    1. Moser MB, Moser EI, Forrest E, Andersen P, Morris RG (1995) Spatial learning with a minislab in the dorsal hippocampus. PNAS 92(21): 9697–9701.
    1. Parker BA, Thompson PD, Jordan KC, Grimaldi AS, Assaf M, et al. (2011) Effect of exercise training on hippocampal volume in humans: a pilot study. Res Q Exerc Sport 82(3): 585–591.
    1. Pereira A, Huddleston D, Brickman A, Sosunov S, Hen R, et al. (2007) An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. PNAS 104(13): 5638–5643.
    1. Pajonk FG, Wobrock T, Gruber O, Scherk H, Berner D, et al. (2010) Hippocampal Plasticity in Response to Exercise in Schizophrenia. Arch Gen Psychiatry 67(2): 133–143.
    1. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, et al. (2011) Exercise training increases size of hippocampus and improves memory. PNAS 108(7): 3017–3022.
    1. Benson M, Blumenthal J, Babyak M, Smith P, Rogers S, et al. (2008) Exercise fails to improve neurocognition in depressed middle-aged and older adults. Med Sci Sports Exerc 40(7): 1344–1352.
    1. Thomas G, Jiang C, Taheri S, Xiao Z, Tomlinson B, et al. (2010) A systematic review of lifestyle modifications and glucose intolerance in the prevention of type 2 diabetes. Curr Diabetes Rev 6(6): 378–387.
    1. Dantzer R, ÓConnor J, Freund G, Johnson R,Kelley K (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Rev 946–57.
    1. Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, et al. (2010) Association of high-sensitivity C-reactive protein with de novo major depression. Brit J Psychiatry 197(5): 372–377.
    1. Schiepers OJG, Wichers MC,Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29(2) 201–217.
    1. Kadoglou N, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, et al... (2007) The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 14837–843.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa